Accéder au contenu
Merck
Toutes les photos(2)

Documents

1.41464

SAFC

Parteck® MXP (Polyvinyl alcohol 4-88)

EMPROVE® ESSENTIAL, Ph. Eur., ChP, JPE, USP

Fabrication pharma

Synonyme(s) :

Parteck® Polyvinyl alcohol, PVA, PVOH

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(2)

About This Item

Formule linéaire :
(C2H4O)n
Numéro CAS:
9002-89-5
Numéro MDL:
MFCD00081922
Code UNSPSC :
13111042

Agence

ChP
JPE
Ph. Eur.
USP

Niveau de qualité

500

Gamme de produits

EMPROVE® ESSENTIAL

Forme

fine powder

Taille des particules

≤200 μm (d95)

Pf

160-240 °C

Application(s)

controlled release
pharmaceutical
solid formulation
solubility enhancement

Température de stockage

15-25°C

InChI

1S/C2H4O/c1-2-3/h2-3H,1H2

Clé InChI

IMROMDMJAWUWLK-UHFFFAOYSA-N

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Catégories apparentées

Description générale

With formulation challenges in mind, we have used particle engineering technologies to develop functional excipients specifically for solid dosage forms. The products in our Parteck® portfolio feature unique particle properties tailored for excellent performance in tableting processes, for specific drug delivery technologies, or for solubility enhancement.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

Application

Parteck® MXP excipient is a polyvinyl alcohol-based excipient specifically designed for hot-melt extrusion to increase the solubility of poorly water soluble APIs via stabilization of the amorphous solid state. Parteck® MXP enables stable and high drug loads and can be used for a broad range of poorly water soluble APIs and a variety of final dosage forms.

Caractéristiques et avantages

  • Superior supersaturation performance via precipitation inhibition
  • High thermostability up to 250°C, extending the potential application range
  • Stable high drug loads and suitability with a broad range of APIs
  • Flexible release kinetics
  • Compatible with several downstream processing capabilities, like direct compression, continuous manufacturing, thin film extrusion and 3D printing
  • Optimized powder properties for excellent performance in the HME process
  • Suitable polymer properties for HME, spray drying and 3D printing processes

Informations légales

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
PARTECK is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

Application

Réf. du produit
Description
Tarif

Produit(s) apparenté(s)

Réf. du produit
Description
Tarif

Souvent commandé avec ce produit

Réf. du produit
Description
Tarif

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 1

Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Articles

Solid Formulation Development Using Melt-based 3D Printing Technologies

3D printing can overcome challenges during formulation development, with a focus on enhancing API bioavailability in solid dispersions. Find out how in this technical article.

Solid Formulation Development Using Melt-based 3D Printing Technologies

3D printing can overcome challenges during formulation development, with a focus on enhancing API bioavailability in solid dispersions. Find out how in this technical article.

Solid Formulation Development Using Melt-based 3D Printing Technologies

3D printing can overcome challenges during formulation development, with a focus on enhancing API bioavailability in solid dispersions. Find out how in this technical article.

API Solubility and Dissolution Enhancement Via Formulation

Our overview of API solubility and dissolution enhancement methods can help you decide between the many options to take during formulation.

Afficher tout

Contenu apparenté

3D Printed Precision: Selective Laser Sintering for Oral Drug Delivery

For selective laser sintering (SLS) polymers are needed for a successful workflow and selection of the best approach requires consideration of several factors.

3D Printed Precision: Selective Laser Sintering for Oral Drug Delivery

For selective laser sintering (SLS) polymers are needed for a successful workflow and selection of the best approach requires consideration of several factors.

3D Printed Precision: Selective Laser Sintering for Oral Drug Delivery

For selective laser sintering (SLS) polymers are needed for a successful workflow and selection of the best approach requires consideration of several factors.

3D Printed Precision: Selective Laser Sintering for Oral Drug Delivery

For selective laser sintering (SLS) polymers are needed for a successful workflow and selection of the best approach requires consideration of several factors.

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique